Cresset Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Sell |
|
|||||
|
2025
Q1 | $851K | Buy |
|
|||||
|
2024
Q4 | $1.04M | Sell |
|
|||||
|
2024
Q3 | $1.33M | Buy |
|
|||||
|
2024
Q2 | $1.23M | Sell |
|
|||||
|
2024
Q1 | $1.64M | Sell |
|
|||||
|
2023
Q4 | $1.44M | Sell |
|
|||||
|
2023
Q3 | $1.36M | Buy |
|
|||||
|
2023
Q2 | $923K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $250K | Buy |
|
|||||
|
2021
Q3 | $274K | Buy |
|
|||||
|
2021
Q2 | $200K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $47K | Buy |
|
|||||
|
2018
Q4 | $19K | Buy |
|